Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabián Pitoia

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Clinical Case Reports|May 3, 2021
Complete response to larotrectinib treatment in a patient with papillary thyroid cancer harboring an <i>ETV6-NTRK3</i> gene fusionFabián Pitoia
Archives of Endocrinology and Metabolism|September 5, 2019
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin AmericaAnabella Smulever, Fabián Pitoia
Endocrine|April 25, 2020
High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillanceAnabella Smulever, Fabián Pitoia
Endocrine|January 7, 2021
Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?Anabella Smulever, Fabián Pitoia
Endocrine|May 27, 2025
A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation ratesAnabella Smulever, Fabián Pitoia
Medicina|December 18, 2012
[Thyroid cancer. In search of individualized treatment]Fabián Pitoia, Andrea Cavallo
Drug Design, Development and Therapy|April 5, 2016
Selective use of sorafenib in the treatment of thyroid cancerFabián Pitoia, Fernando Jerkovich
Clinical Nuclear Medicine|July 8, 2014
Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancerFabián Pitoia, Fernanda Bueno, Graciela Cross
Frontiers in Endocrinology|July 11, 2022
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic ReviewVerdiana Caironi, Fabián Pitoia, Pierpaolo Trimboli
European Thyroid Journal|March 12, 2015
Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastasesFabián Pitoia, Erika Abelleira, Graciela Cross
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Clinical Case Reports|May 3, 2021
Complete response to larotrectinib treatment in a patient with papillary thyroid cancer harboring an <i>ETV6-NTRK3</i> gene fusionFabián Pitoia
Archives of Endocrinology and Metabolism|September 5, 2019
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin AmericaAnabella Smulever, Fabián Pitoia
Endocrine|April 25, 2020
High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillanceAnabella Smulever, Fabián Pitoia
Endocrine|January 7, 2021
Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?Anabella Smulever, Fabián Pitoia
Endocrine|May 27, 2025
A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation ratesAnabella Smulever, Fabián Pitoia
Medicina|December 18, 2012
[Thyroid cancer. In search of individualized treatment]Fabián Pitoia, Andrea Cavallo
Drug Design, Development and Therapy|April 5, 2016
Selective use of sorafenib in the treatment of thyroid cancerFabián Pitoia, Fernando Jerkovich
Clinical Nuclear Medicine|July 8, 2014
Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancerFabián Pitoia, Fernanda Bueno, Graciela Cross
Frontiers in Endocrinology|July 11, 2022
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic ReviewVerdiana Caironi, Fabián Pitoia, Pierpaolo Trimboli
European Thyroid Journal|March 12, 2015
Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastasesFabián Pitoia, Erika Abelleira, Graciela Cross
Pageof 7